25-羟基维生素 D2结构式
|
常用名 | 25-羟基维生素 D2 | 英文名 | 25-Hydroxycalciferol |
---|---|---|---|---|
CAS号 | 21343-40-8 | 分子量 | 412.648 | |
密度 | 1.0±0.1 g/cm3 | 沸点 | 542.3±38.0 °C at 760 mmHg | |
分子式 | C28H44O2 | 熔点 | 45-51ºC | |
MSDS | 中文版 美版 | 闪点 | 225.9±21.4 °C | |
符号 |
GHS02, GHS07 |
信号词 | Danger |
25-羟基维生素 D2用途Ercalcidiol 是一种 vitamin D2 代谢物,作为 vitamin D 营养状态的指标。 |
中文名 | 25-羟基维生素 D2 |
---|---|
英文名 | 25-hydroxyvitamin D2 |
中文别名 | 25-羟麦角甾醇 | 25-羟基维他命D2(25-羟麦角甾醇) | 25-羟基维生素D2 | 25-羟基维生素d2 | 25-羟基维生素 |
英文别名 | 更多 |
描述 | Ercalcidiol 是一种 vitamin D2 代谢物,作为 vitamin D 营养状态的指标。 |
---|---|
相关类别 | |
靶点 |
Human Endogenous Metabolite |
体外研究 | Ercalcidiol(25(OH)D2)和25(OH)D3之间的区别对于监测维生素D治疗非常重要,因为维生素D2是主要的处方形式。 Ercalcidiol的半衰期短于25(OH)D3的半衰期,并且它与维生素D结合蛋白的结合较差,使其效力较低,因此需要以比维生素D3高得多的剂量给药。一些目前使用的检测方法检测Ercalcidiol的能力降低,当试图用维生素D2监测治疗时,这会导致危险的过量给药[2]。 |
参考文献 |
密度 | 1.0±0.1 g/cm3 |
---|---|
沸点 | 542.3±38.0 °C at 760 mmHg |
熔点 | 45-51ºC |
分子式 | C28H44O2 |
分子量 | 412.648 |
闪点 | 225.9±21.4 °C |
精确质量 | 412.334137 |
PSA | 40.46000 |
LogP | 7.56 |
蒸汽压 | 0.0±3.3 mmHg at 25°C |
折射率 | 1.543 |
储存条件 | −20°C |
符号 |
GHS02, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H225-H319 |
警示性声明 | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
个人防护装备 | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) | T+,F |
风险声明 (欧洲) | 24/25-26-48/25-11 |
安全声明 (欧洲) | 28-36/37-45-16-7 |
危险品运输编码 | UN2811 6 |
25-羟基维生素 D2上游产品 8 | |
---|---|
25-羟基维生素 D2下游产品 1 | |
Improved analysis of vitamin D metabolites in plasma using liquid chromatography tandem mass spectrometry, and its application to cardiovascular research.
Biomed. Chromatogr. 28(6) , 913-7, (2014) The accurate and specific measurement of vitamin D is increasingly important for determining the role of vitamin D in the pathogenesis of disease. Liquid chromatography coupled to tandem mass spectrom... |
|
Common variants in CYP2R1 and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D₃-fortified bread and milk during winter in Denmark.
Am. J. Clin. Nutr. 101(1) , 218-27, (2015) Little is known about how the genetic variation in vitamin D modulating genes influences ultraviolet (UV)B-induced 25-hydroxyvitamin D [25(OH)D] concentrations. In the Food with vitamin D (VitmaD) stu... |
|
Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis.
Epidemiology 24(2) , 310-9, (2013) Higher serum total 25-hydroxyvitamin D (25(OH)D) concentrations have been associated with better lung function and lower risk of allergic disease. 25(OH)D3 constitutes the majority of total 25(OH)D an... |
25-Hydroxy Vitamin D2 |
(3S,5Z,7E,20R,22E)-9,10-Secoergosta-5,7,10,22-tetraene-3,25-diol |
9,10-Secoergosta-5,7,10(19),22-tetraene-3b,25-diol |
9,10-Secoergosta-5,7,10(19),22-tetraene-3β,25-diol |
Ercalcidiol,3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3,25-diol |
EINECS 200-578-6 |
25-Hydroxyvitamin D2 |
25-Hydroxyvitamin D 2 |
25-Hydroxyergocalciferol |
25-Hydroxyergocalciferol 25-Hydroxycalciferol |
Cyclohexanol, 4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1S,3Z)- |
9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol, (3β,5Z,7E,22E)- |
MFCD02683431 |
25-Hydroxycalciferol |
Ercalcidiol |